Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD

Andrea Vukic Dugac (Zagreb, Croatia), Andrea Vukic Dugac, Alen Ruzic, Ana Hecimovic, Mateja Jankovic-Makek, Gordana Pavlisa, Hrvoje Puretic, Gzim Redjepi, Sanja Popovic-Grle, Miroslav Samarzija, Marko Jakopovic

Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Session: Biomarkers and phenotypes of COPD
Session type: Thematic Poster
Number: 3661
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Andrea Vukic Dugac (Zagreb, Croatia), Andrea Vukic Dugac, Alen Ruzic, Ana Hecimovic, Mateja Jankovic-Makek, Gordana Pavlisa, Hrvoje Puretic, Gzim Redjepi, Sanja Popovic-Grle, Miroslav Samarzija, Marko Jakopovic. Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD. Eur Respir J 2016; 48: Suppl. 60, 3661

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012

Endothelial dysfunction and systemic inflammation in different COPD phenotypes
Source: International Congress 2014 – COPD physiopathology
Year: 2014

Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Microparticles in stable and exacerbated COPD patients
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Determinants of heightened systemic inflammation at exacerbation of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 115s
Year: 2006

COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013

Increased small intestinal permeability during severe acute exacerbations of COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016


Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005



The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


Local and systemic inflammation in acute viral exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005

Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015